活動紹介

TOP > 活動紹介 > 2021年度業績

業績

  1. 山﨑行敬、高野知憲、 國島広之. 感染性腸炎・偽膜性腸炎(CDI) 最新ガイドラインに基づく消化器疾患 診療方針 2021;(1):86-90.
  2. 國島広之. 消化器感染症 [薬理・病態・薬物治療]血液・造血器/感染症/悪性腫瘍 2021;:194-197.
  3. 國島広之、竹内萌. 塩酸バンコマイシン、フラジール なんで使うの?医師が考えるくすりの立ち位置
    2022;:16,37.
  4. 中辻侑子, 本橋隆子, 國島広之, 高田礼子. 医学生の喫煙調査:加熱式タバコの普及状況と喫煙場所の遠方移転に伴う喫煙行動の変化. 日本禁煙学会雑誌, 2021;16(2):31-37.
  5. 高野知憲, 山﨑行敬, 國島広之. 新型コロナウイルス感染症と感染対策-CO2センサを使用した換気測定の提案-. クリーンテクノロジー, 2021;31(5):55-57.
  6. 山﨑行敬, 高野知憲, 國島広之. インフルエンザへの抗インフルエンザ薬はどう選ぶ?. 月刊薬事,
    2021;63(7):325-330.
  7. 山﨑行敬, 高野知憲, 國島広之. clostridioides difficile感染症検査. 検査と技術, 2021;49(10):1148-1152.
  8. Nomura S, Eguchi A, Yoneoka D, Kawashima T, Tanoue Y, Murakami M, Sakamoto H, Maruyama-Sakurai K, Gilmour S, Shi S, Kunishima H, Kaneko S, Adachi M, Shimada K, Yamamoto Y, Miyata H.. Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A large cross-sectional national survey. The Lancet Regional Health Western Pacific, 2021;14:100223.
  9. Shinkai M, Tsushima K, Tanaka S, Hagiwara E, Tarumoto N, Kawada I, Hirai Y, Fujiwara S, Komase Y, Saraya T, Koh H, Kagiyama N, Shimada M, Kanou D, Antoku S, Uchida Y, Tokue Y, Takamori M, Gon Y, Ie K, Yamazaki Y, Harada K, Miyao N, Naka T, Iwata M, Nakagawa A, Hiyama K, Ogawa Y, Shinoda M, Ota S, Hirouchi T, Terada J, Kawano S, Ogura T, Sakurai T, Matsumoto Y, Kunishima H, Kobayashi O, Iwata S. Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial. Infect Dis Ther ., 2021;27:1-21.
  10. Nakagama Y, Komase Y, Candray K, Nakagama S, Sano F, Tsuchida T, Kunishima H, Imai T, Shintani A, Nitahara Y, Kaku N, Kido Y. Serological Testing Reveals the Hidden COVID-19 Burden among Health Care Workers Experiencing a SARS-CoV-2 Nosocomial Outbreak. Microbiology Spectrum, 2021;9(2):e1082.
  11. Yoneoka D, Eguchi A, Nomura S, Kawashima T, Tanoue Y, Murakami M, Sakamoto H, Maruyama-Sakurai K, Gilmour S, Shi S, Kunishima H, Kaneko S, Adachi M, Shimada K, Yamamoto Y, Miyata H. Identification of optimum combinations of media channels for approaching COVID-19 vaccine unsure and unwilling groups in Japan. The Lancet Regional Health Western Pacific, 2021;18:100330.
  12. Takano T, Hirose M, Yamasaki Y, Hara M, Okada T, Kunishima H.. Investigation of the incidence of immunisation stress-related response following COVID-19 vaccination in healthcare workers. Journal of Infection and Chemotherapy, 2022;(DOI):10.1016/j.jiac.2022.02.002..
  13. Asaoka K, Sasaki K, Yagi J, Takahashi F, Nagano K, Takano T, Yamasaki Y, Ookawa J, Kunishima H. Alleviation of hand-skin roughness after use of alcohol-based hand rub with inhibitory effects on Staphylococcus aureus – producing δ -toxin. Journal of Infection and Chemotherapy, 2022;28(5):684-689.
  14. TsutidaA, Wada K, Morikane K, Yoshikawa T, Hosomi Y, Dhungel B, Kunishima H.. Characteristics of needlestick and sharps injuries of the hands in the operating room among orthopedic surgeons in Japan. Industrial Health, 2022;:10.2486/indhealth.2021-0194.
  15. Tomoya Tsuchida,Masanori Hirose,Yoko Inoue,Hiroyuki Kunishima,Takehito Otsubo,Takahide Matsuda. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. Journal of Medical Virology, 2022;:1-15.
  16. Tsuchida T, Hirose M, Inoue Y, Kunishima H, Otsubo T, Matsuda T.. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. Journal of Medical Virology, 2022;(DOI):10.1002/jmv.27689.
  17. Kawasaki T, Ooka S, Mizushima M, Nakamura Y, Ikeda H, Sakurada T, Suzuki S, Yamazaki K, Goto Y, Sakurai K, Yamasaki Y, Kiyokawa T, Tonooka K, Kunishima H, Kawahata K.. COVID-19 and Adult-onset Still's Disease as part of Hyperferritinemic Syndromes. Modern Rheumatology Case Reports, 2022;6(1):101-105.
  18. Takada K, Nakamura M, Samura M, Inoue J, Hirose N, Kurata T, Nagumo H, Ishii J, Koshioka S, Tanikawa K, Kunishima H.. Suppurative Thrombophlebitis of the Posterior Neck Caused by Streptococcus constellatus: A Case Report and Literature Review. Yakugaku Zasshi, 2022;142(2):189-193.
  19. Kamata Kazuhiro, Jindai Kazuaki, Ichihara Nao, Saito Hiroki, Kato Hideaki, Kunishima Hiroyuki, Shintani Ayumi, Nishida Osamu, Fujitani Shigeki. Why participation in an international clinical trial platform matters during a pandemic? Launching REMAP-CAP in Japan. Journal of Intensive Care, 2021;9:DOI-10.1186/s40560-021-00547-7.